[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Loughborough University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":222},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,54,87,119,146,170,195],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100589347","acute-impact-of-whey-protein-enriched-milk-fat-globule-membrane-supplementation-on-postprandial-markers-of-heart-and-brain-health-100589347",false,"NCT06953232","Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health","Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health in Postmenopausal Women Living With Overweight and at Moderate Risk for Cardiovascular Disease.","Inclusion Criteria:\n\n* Apparently healthy postmenopausal women (not menstruating for 12 or more months)\n* Aged 50 - 75 years\n* BMI: 25 - 40 kg\u002Fm²\n* Moderate CVD risk\n* Recreationally active (\\> 3 x 30 min moderate exercise per week)\n* Understands and is willing and able to comply with all study procedures including eating a high-fat breakfast meal\n* Fluent in written and spoken English\n* Access to, and able to use, the internet\u002Fcomputer\u002Ftablet device\n\nExclusion Criteria:\n\n* Smoking (including vaping)\n* Diagnosed with cardiovascular disease or suffered myocardial infarction \u002Fstroke in the past twelve months\n* Existing or significant past medical history of any medical condition likely to affect the study outcomes e.g., diabetes, digestive, cancer or thyroidal disease, neurological disease (Alzheimer's disease, other form of dementia, mild cognitive impairment), or serious mental illness know to affect cognition (schizophrenia, schizoaffective disorder, bipolar disorder), learning disorders (dyslexia)\n* Early or premature menopause resulting from medical conditions or undergoing surgery\n* Hormone replacement therapy within last 6 months\n* Prescribed medications likely to interfere with study outcomes (including lipid\u002Fcholesterol-lowering medications, including statins; blood thinners, antiplatelets (anticoagulants) such as heparin, etc.; medications for blood pressure; inflammation such as nonsteroidal anti-inflammatory drugs, aspirin, etc.; immune function, or lipid\u002Fcarbohydrate metabolism) or prescribed antibiotics within the last three months\n* Use of antidepressant or anti-anxiety medication if it has changed in the last three months or expected to change within the 3-month study period\n* Taking vitamin, mineral, or fatty acid supplements (e.g., fish oil, calcium) or unwilling stop consuming these for the duration of the study (including sufficient washout period)\n* Working night shifts\n* Inaccessible veins for blood collection via cannulation\n* Unstable weight history (≥3 kg loss or gain in the previous 3 months) or planning or currently on a weight reduction scheme\n* Known allergy or intolerance to study food (including lactose intolerance, dairy, and wheat)\n* Being vegan or any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study\n* Excessive alcohol consumption: \\>21 unit\u002Fwk (i.e., more than 10 and a half pints of beer or 21 small glasses of wine)\n* Currently taking part or have participated in another research study in the last two months (e.g., dietary intervention)",true,"FEMALE","50 Years","75 Years",{"count":21,"type":22},16,"ESTIMATED","INTERVENTIONAL",[25],"NA","In a single-blind, randomised, placebo-controlled crossover manner, this study aims to assess the impact of a high-fat mixed meal containing a whey protein (WP)-enriched milk fat globule membrane (MFGM) powdered ingredient on markers of heart and brain health in the fed state among middle-to-older-aged, postmenopausal women living with overweight and at moderate risk for cardiovascular disease.\n\nParticipants will attend two \\~8 hour study visits, where they will consume a high-fat meal containing a WP-enriched MFGM powdered ingredient or a placebo WP-based powdered ingredient. Each visit will involve anthropometric measurements and periodic assessments of heart health, including blood pressure and blood vessel stiffness measurements, blood sample collections, as well as computer-based tests measuring mood and cognition (brain function) over a 6-hour postprandial period.",[28,29,30,31,32],"Cardiovascular Diseases","Cognition","Overweight or Obesity","Postmenopausal Women","Cardiometabolic Risk Factors",[34,35,36,37,38,39,40],"Milk fat globule membrane","Milk polar lipids","triacylglycerol","postprandial","cholesterol","cardiometabolic disease risk","cognitive function","RECRUITING","2026-05-18",{"date":44,"type":45},"2026-05-20","ACTUAL",{"date":47,"type":45},"2025-09-30",{"date":49,"type":22},"2026-10",{"name":51,"class":52},"Loughborough University","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":62,"minAge":63,"maxAge":4,"enrollmentInfo":64,"targetDuration":4,"studyType":23,"phases":66,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":53},"100638799","enhancing-exercise-adherence-among-patients-with-lateral-hip-pain-100638799","NCT07597343","Enhancing Exercise Adherence Among Patients With Lateral Hip Pain","The 'As Soon As Possible (ASAP)' Intervention for Enhancing Therapeutic Exercise Adherence Among Patients With Greater Trochanteric Pain Syndrome (GTPS): A Feasibility Trial","ASAP","Inclusion Criteria:\n\n1. Diagnosis of Greater Trochanteric Pain Syndrome (GTPS): Participants must have been diagnosed with GTPS by a qualified healthcare provider\n2. Age: Participants aged 18 years or above\n3. Willingness to Participate: Participants must express a willingness to participate in the study\n4. Ability to Understand and Provide Informed Consent: Participants must be able to comprehend the study details, provide informed consent, and actively engage in the intervention and assessment processes\n5. Ability to Perform Prescribed Exercises: Participants should be physically able to perform the prescribed exercises safely to actively engage in the intervention as assessed by their NHS treating healthcare practitioner\n6. Having a mobile phone\n\nExclusion Criteria:\n\n1. Age: Participants aged under 18 years.\n2. Severe Medical or Psychiatric Conditions: Participants who suffer from severe medical or psychiatric disorders that could significantly impact their ability to engage in the intervention or comply with the exercise program will not be included.","ALL","18 Years",{"count":65,"type":22},60,[25],"Greater Trochanteric Pain Syndrome (GTPS) is a condition that causes pain on the outer side of the hip. This clinical trial tests a simple exercise timing approach for adults with GTPS.\n\nThe main questions it aims to answer are:\n\n* Can enough people with GTPS be recruited and complete this study?\n* How many participants fill in their questionnaires at all five check-ins?\n* Do participants find the exercise timing approach easy and acceptable?\n\nResearchers will compare three groups. Each group receives different guidance on when to do their exercises. This will show whether timing guidance (with or without reminders) works better than usual care.\n\nParticipants will:\n\n* Follow a prescribed hip exercise programme set by their healthcare provider\n* Fill in a short daily survey (1-2 minutes) for 28 days\n* Complete online questionnaires about hip pain, movement, and exercise at five - points over about three months\n* Join an online group discussion at the end of the study\n\nAdults aged 18 and over may take part if they:\n\n* Have been diagnosed with GTPS by a healthcare provider\n* Are able to exercise safely\n* Own a mobile phone\n\nTaking part may help participants keep up with their prescribed exercises, which may in turn reduce hip pain and improve daily activities. It could also help researchers find better ways to support people with GTPS in the future.",[69,70],"Greater Trochanter Pain Syndrome","Hip Pain",[72,73,74,75,76,77,78],"Greater Trochanteric Pain Syndrome","Exercise adherence","Feasibility trial","Behavioural intervention","Hip pain","Rehabilitation","Exercise timing","2026-05-15",{"date":81,"type":45},"2026-05-19",{"date":83,"type":45},"2025-09-01",{"date":85,"type":22},"2027-03-31",{"name":51,"class":52},{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":16,"sex":17,"minAge":95,"maxAge":19,"enrollmentInfo":96,"targetDuration":4,"studyType":23,"phases":98,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":110,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":53},"100613494","bone-health-in-postmenopausal-women-the-effect-of-exercise-with-or-without-medication-for-osteoporosis-100613494","NCT07267325","Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis","The Effect of Exercise With or Without Antiresorptive Therapy, on Bone Properties in Postmenopausal Women With Low BMD - Randomised Controlled Unilateral Intervention Trial","BEAT-OP","Inclusion Criteria:\n\n* Women aged 55-75 years old\n* \\>4y since menopause\u002Fhysterectomy\u002Foophorectomy.\n* Baseline femoral neck or lumber spine BMD T-score between -1 and -3.\n* Able to complete the hopping exercises.\n* Have no regular involvement for more than once\u002Fweek in:\n\n  1. Strength, powerlifting or high load resistance exercise.\n  2. High to moderate impact exercise that known to involve ground reaction forces 2 to 4 times greater than body weight (e.g. Jogging).\n* Treatment group: taking antiresorptive treatment for osteoporosis continuously for at least 12 months, and who intend to continue this medication for the rest of the study.\n* Control group: not taking any medication affecting bone and no intention to commence such medication for the rest of the study.\n\nExclusion Criteria:\n\n* Body mass index (BMI) \\>35 kg\u002Fm2\n* Any medical condition, surgery, or injuries that contraindicate exercises including lower limb or back pain, knee or hip osteoarthritis.\n* Vertebral fracture or multiple low trauma fractures (recent expert consensus recommends lower impact exercise for these groups)\n* Replacement of hip joint(s)","55 Years",{"count":97,"type":22},110,[25],"Osteoporosis is a systemic bone disorder characterised by a reduced bone mass and structural deterioration, increasing the risk of fragility fractures, particularly in women post-menopause. Bone mass and structure can be assessed by scans.\n\nAntiresorptive medications are commonly prescribed to reduce bone resorption, preventing further bone loss and thus reducing the possibility of fracture. Exercise can also benefit bone mass and structure but current evidence do not show whether exercise is more, or less, effective in combination with antiresorptive medication.\n\nThis study will compare the effect of a brief, home-based exercise programme on bone mineral and structural properties in women taking\u002F not taking antiresorptive medication.",[101],"Osteoporosis in Post-menopausal Women",[103,104,105,106,107,108,109],"Exercise","Bone mineral density","Bone strength","Bone geometry","Fracture risk","Bone structure","Biomarkers","NOT_YET_RECRUITING","2025-12-04",{"date":113,"type":45},"2025-12-05",{"date":115,"type":22},"2026-01-01",{"date":117,"type":22},"2027-09",{"name":51,"class":52},{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":123,"acronym":4,"eligibilityCriteria":124,"healthyVolunteers":16,"sex":62,"minAge":63,"maxAge":125,"enrollmentInfo":126,"targetDuration":4,"studyType":23,"phases":128,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":110,"whyStopped":4,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":4},"100591606","glycemic-control-following-occupational-work-in-a-hot-environment-100591606","NCT06982612","Glycemic Control Following Occupational Work in a Hot Environment","Inclusion Criteria:\n\n* Male or female\n* Generally fit and healthy\n* Participate in endurance or intermittent exercise at least 3 times a week or minimum of 150 minutes moderate intensity activity per week\n\nExclusion Criteria:\n\n* Under 18 or 45 and over,\n* any morbidity or medication that might influence carbohydrate\u002Ffat metabolism (i.e., liver\u002Frenal\u002Fcardiovascular disease) or cycling ability (musculoskeletal injury etc),\n* coagulation or bleeding disorders,\n* blood-borne illness,\n* heart conditions,\n* congenital heart disease,\n* uncontrolled exercise-induced asthma,\n* smoking (including vaping),\n* allergies to the products used in the study,\n* dieting or restrained eating behaviours.\n* Females with amenorrhea would be an exclusion criteria.","45 Years",{"count":127,"type":22},20,[25],"Occupational workers regularly perform physically demanding tasks in hot environments, exposing them to heat stress and potential dehydration. While the physiological impacts of heat exposure are well-documented, its effects on glycemic control remain less understood. Given the rising global temperatures due to climate change and the increasing prevalence of metabolic disorders such as obesity and type 2 diabetes, it is essential to investigate how heat exposure during work influences glycemic regulation. Understanding these interactions will help inform future occupational health guidelines and metabolic health recommendations in physically demanding industries.",[131],"Plasma Glucose Following Prolonged Heat Exposure",[133,134,135,136,137],"heat","plasma glucose","worker","glycemia","OGTT","2025-05-18",{"date":140,"type":45},"2025-05-21",{"date":142,"type":22},"2025-05",{"date":144,"type":22},"2026-10-01",{"name":51,"class":52},{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":16,"sex":62,"minAge":63,"maxAge":19,"enrollmentInfo":153,"targetDuration":4,"studyType":23,"phases":155,"briefSummary":156,"conditions":157,"keywords":160,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":167,"leadSponsor":169,"locationsCount":53},"100560177","effect-of-12-week-milk-fat-globule-membrane-supplementation-on-the-human-muscle-function-of-healthy-recreationally-active-adults-100560177","NCT06573749","Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults","Effect of 12-week Bioactive Whey Protein Concentrate Supplementation on the Neuromuscular System of Healthy, Recreationally Active Adults","Inclusion Criteria:\n\n* 18-30 or 60-75 years old\n* Male or female\n* Healthy with no contraindications to exercise\n* Classified as recreationally active (meet the government's guidelines for weekly physical activity - 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity)\n\nExclusion Criteria:\n\n* Any injury, medical condition or symptom precluding the ability to complete strenuous exercise as identified by the health screen questionnaire and physical activity readiness questionnaire\n* Uncontrolled hypertension (blood pressure of 140\u002F90 mmHg or higher) as identified by recording resting blood pressure\n* Neuromuscular or musculoskeletal disease\n* Occurrence of a severe injury to the lower limbs or back within the previous 6 months (time loss of \\> 21 days of normal activity)\n* Occurrence of a minor injury to the lower limbs or back within the previous month (time loss of \\>1 day of normal activity)\n* Do not meet the government guidelines of minimum weekly physical activity as revealed by the IPAQ-SF\n* Allergic to dairy or pea, or lactose intolerant\n* Complete greater than 6 hours structured exercise per week as revealed by the exercise and physical activity form\n* Consumption of supplements that may confound the results of the present study within the previous 3 months (includes any form of protein supplement, creatine, pre-workout supplements, any form of testosterone supplement, amino acids, beta-alanine, beta- hydroxy-beta-methylbutyrate (HMB), fish or krill oil, collagen supplements, any choline- containing supplement, or any phospholipid-containing supplement) as highlighted by the health screen questionnaire\n* Taking anticoagulants or antiplatelet drugs\n* Use of antidepressant\u002Fanti-anxiety medication\n* Having a blood borne virus, or a partner who has a blood-borne virus\n* Extreme diet classified as identified by the food-frequency questionnaire",{"count":154,"type":22},96,[25],"The main aim of this study is to understand if chronic supplementation (12 weeks) of a milk fat globule membrane containing supplement, called bioactive whey protein concentrate, improves human muscle function greater than a placebo supplement within a cohort of healthy, recreationally active adults. Furthermore, we aim to investigate whether any potential benefits of milk fat globule membrane are influenced by age through the assessment of 2 distinct age subgroups (young and older). We hypothesise that neuromuscular function (strength and power) will increase from pre to post within the group that consumes bioactive whey protein concentrate but not the placebo group, with a greater increase in the older group compared to the young group.",[158,159],"Ageing Well","Neuromuscular Function",[161,162,34],"Nutrition","Neuromuscular","2025-03-28",{"date":165,"type":45},"2025-04-02",{"date":163,"type":45},{"date":168,"type":22},"2026-01",{"name":51,"class":52},{"id":171,"slug":172,"hasResults":11,"nctId":173,"briefTitle":174,"officialTitle":174,"acronym":4,"eligibilityCriteria":175,"healthyVolunteers":16,"sex":62,"minAge":63,"maxAge":125,"enrollmentInfo":176,"targetDuration":4,"studyType":23,"phases":177,"briefSummary":178,"conditions":179,"keywords":181,"overallStatus":110,"whyStopped":4,"lastUpdateSubmitDate":187,"lastUpdatePostDateStruct":188,"startDateStruct":190,"completionDateStruct":192,"leadSponsor":194,"locationsCount":53},"100579566","the-effect-of-hydration-on-postprandial-metabolic-responses-100579566","NCT06825962","The Effect of Hydration on Postprandial Metabolic Responses","Inclusion Criteria:\n\n* Male or female\n* Generally fit and healthy\n* Participate in endurance or intermittent exercise at least 3 times a week or minimum of 150 minutes moderate intensity activity per week\n\nExclusion Criteria:\n\n* \\\u003C 18 or \\> 45\n* Any health condition that may affect study outcomes (e.g., endocrine\u002Fliver\u002Frenal\u002Fcardiovascular disease)\n* Any morbidity that affects ability to cycle\n* Smoker or vaper",{"count":21,"type":22},[25],"Certain populations, such as industrial workers and endurance athletes are particularly susceptible to dehydration due to exposure to heat for long periods of time causing evaporative water loss via sweating. The physical and cognitive decrements associated with dehydration have been widely researched, however the effect of dehydration on metabolism is lesser known. As climate change is causing temperatures to rise, and metabolic diseases such as type 2 diabetes are more common, the effect of dehydration on metabolism, specifically glycemic response to meals, needs to be established for future recommendations in clinical, environmental and athletic settings.\n\nTherefore, the aim of this study is to investigate the effect of acute exercise-induced dehydration on subsequent metabolic responses to feeding (i.e. glycaemia and insulinaemia).",[180],"Glycaemia",[182,183,184,185,180,186],"Hydration","Dehydration","Hypohydration","Glycemia","Glucose control","2025-02-10",{"date":189,"type":45},"2025-02-13",{"date":191,"type":22},"2025-03",{"date":193,"type":22},"2025-12",{"name":51,"class":52},{"id":196,"slug":197,"hasResults":11,"nctId":198,"briefTitle":199,"officialTitle":200,"acronym":201,"eligibilityCriteria":202,"healthyVolunteers":16,"sex":62,"minAge":63,"maxAge":4,"enrollmentInfo":203,"targetDuration":4,"studyType":23,"phases":204,"briefSummary":205,"conditions":206,"keywords":210,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":213,"lastUpdatePostDateStruct":214,"startDateStruct":216,"completionDateStruct":218,"leadSponsor":220,"locationsCount":221},"100567554","exercise-therapy-in-axial-spa-inflammation-and-biologic-therapy-extasi-b-100567554","NCT06669702","EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B)","EXercise As an Anti-inflammatory Treatment in Axial Spondyloarthritis (axSpA) for Patients Taking Biologic Therapy: a Proof of Concept Study (ExTASI-B).","ExTASI-B","Inclusion Criteria:\n\n* Diagnosis of axSpA by a consultant rheumatologist\n* Age=\u002F\\>18 years old\n* Without other significant cardiovascular comorbidities\n* Receiving stable dose biologic treatment\n* Able to commit to the time demands of the study\n\nExclusion Criteria:\n\n* Unable to undertake exercise due to physical or psychological barriers\n* Presence of hip or peripheral joint disease\n* Contraindication to exercise training (American College of Sports Medicine guidelines)\n* Excessively active (score of high on IPAQ)\n* Unable to communicate sufficiently in English\n* Female participants who are pregnant, lactating, or planning pregnancy during the course of the study.\n* Inability to give informed consent or comply with testing and training protocol for any reason.\n* Presence of chronic anaemia (haemoglobin less than 13.5 g\u002FdL for men; less than 12.0 g\u002FdL for women; or haematocrit less than 41.0% in men, less than 36.0% in women.\n* Co-morbidity that the research team determine to be a contraindication to involvement\n\nInclusion and exclusion criteria of healthy controls:\n\nInclusion Criteria:\n\n* Aged between 18 years old and 65 years old\n* Not taking any long-term medication that affects inflammation or immune-mediated inflammation.\n* Free from infection or infection symptoms\n\nExclusion criteria:\n\nThe participant may not enter the study if ANY of the following apply:\n\n* Unable to undertake exercise due to physical or psychological barriers\n* Excessively active (score of high on IPAQ)\n* Unable to communicate sufficiently in English\n* Female participants who are pregnant, lactating, or planning pregnancy during the course of the study.\n* Inability to give informed consent or comply with testing and training protocol for any reason.\n* Have been diagnosed with or are aware of at least one of the following health issues:\n* Immune system disorder\n* Cardiovascular and\u002For cardiometabolic diseases, including but not limited to high blood pressure, high triglycerides and\u002For cholesterol levels, diabetes mellitus, etc.\n* Any chronic health condition that affects one's ability to partake in physical activity\n* Musculoskeletal injury that affects one's ability to partake in physical activity",{"count":65,"type":22},[25],"The goal of this randomised controlled trial study is to investigate whether exercise (brisk walking, equal to 13 on a rating of perceived exertion scale; somewhat hard) can be used as an adjuvant therapy for people living with axial spondyloarthritis and taking biologic medications to further improve their quality of life and lower their symptoms and disease burden. The main questions it aims to answer are:\n\nDoes a 12-week structured home-based aerobic exercise intervention have a favourable effect on markers of immune-mediated inflammation and symptom severity?\n\nAs a secondary aim and outcome, this study will investigate:\n\n* The acceptability of this intervention using questionnaires with free text boxes and one-to-one semi-structured interviews in a subset (50%) of participants (Q-ExTASI-B substudy).\n* The effect of the home-based intervention on circulating markers of cardiometabolic health, anthropometrical measures, and immune markers that associate with systemic inflammation.\n* The effect of the home-based intervention on objective measures of physical function and exercise tolerance\n\nThe study will compare the data of a healthy group with that of people living with axial spondyloarthritis. Within the patient population, 20 of the individuals will be allocated to the exercise group (randomly), and 20 will be allocated to the usual care group. In the exercise group, participants will be asked to do 30 minutes of brisk walking five days a week for 12 weeks, and they will be visiting Loughborough University every four weeks to provide blood samples and fill out questionnaires. Participants in the usual care group will continue with their current care routine and will visit the study site to provide blood samples and questionnaire data every 4 weeks. The data from all axSpA patients will be compared to healthy controls, and subgroup analysis will be conducted to investigate the difference between the exercise group and the usual care group.",[207,208,209],"Axial Spondyloarthrithis","Inflammatory Diseases","Arthritis",[103,211,212],"Inflammation","Immunosenescence","2024-11-03",{"date":215,"type":45},"2024-11-05",{"date":217,"type":45},"2024-08-01",{"date":219,"type":22},"2029-07-31",{"name":51,"class":52},2,""]